Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus (2023)
Attributed to:
Stratified Medicine to Optimise Treatment for Hepatitis C Virus Infection
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0280551
PubMed Identifier: 36689413
Publication URI: http://europepmc.org/abstract/MED/36689413
Type: Journal Article/Review
Parent Publication: PLOS ONE
Issue: 1
ISSN: 1932-6203